CAS: 119413-55-7; 3-(2-((4-Fluorobenzyl)(Methyl)Amino)Ethyl) 5-Isopropyl 4-(Benzo[d][1,3]Dioxol-4-yl)-2,6-Dimethyl-1,4-Dihydropyridine-3,5-Dicarboxylate

该化合物是一种制药化合物,主要被归类为钙管阻塞器,具体针对L型钙管,用于管理高血压和某些心血管疾病,该物质展示了一种独特的行动机制,不仅有助于血管变异,而且具有潜在的...

结构式图片

MSDS等安全信息

    合成工艺路线路线简述

      海关参考信息

      专利信息


      专利号:US-2008287407-A1
      优先权日:2003-12-10
      标题 :Nitric Oxide Releasing Pyruvate Compounds, Compositions and Methods of Use
      发明人:GARVEY DAVID S; FANG XINQIN; KHANAPURE SUBHASH P; RANATUNGA RAMANI R; WEY SHIOW-JYI
      权利人:NITROMED INC
      摘要:The invention describes novel nitrosated and/or nitrosylated pyruvate compounds and pharmaceutically acceptable salts thereof, and novel compositions comprising at least one nitrosated and/or nitrosylated pyruvate compound, and, optionally, at least one compound that donates, transfers or releases nitric oxide, stimulates endogenous synthesis of nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor or is a substrate for nitric oxide synthase, and/or at least one therapeutic agent. The invention also provides novel compositions comprising at least one pyruvate compound and at least one compound that donates, transfers or releases nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor, stimulates endogenous synthesis of nitric oxide or is a substrate for nitric oxide synthase and/or at least one therapeutic agent. The invention also provides novel kits comprising at least one pyruvate compound, that is optionally nitrosated and/or nitrosylated, and, optionally, at least one nitric oxide donor and/or at least one therapeutic agent. The invention also provides methods for treating diseases resulting from oxidative stress, diabetes, reperfusion injury following ischemia, preservation of tissues, organs, organ parts and/or limbs.

      专利号:US-2008214827-A1
      优先权日:2004-02-03
      标 题:Synthesis of Cyanoimino-Benzoimidazoles
      发明人:GOEHRING R RICHARD; WHITEHEAD JOHN; SHAO BIN
      权利人:EURO CELTIQUE SA
      摘要:Disclosed in certain embodiments is a process for synthesizing a compound of formula (V) and salts thereof.

      专利号:CA-2555219-A1
      优先权日:2004-02-03
      标 题 :Synthesis of cyanoimino-benzoimidazoles

      专利号:WO-2005075459-A1
      优先权日:2004-02-03
      标题:Synthesis of cyanoimino-benzoimidazoles

      专利号:EP-1711484-A4
      优先权日:2004-02-03
      标题:SYNTHESIS OF CYANOIMINO-BENZOIMIDAZOLES

      专利号:EP-1711484-A1
      优先权日:2004-02-03
      标 题:Synthesis of cyanoimino-benzoimidazoles

      供应商参考报价(招募中)

      品牌试剂参考报价(招募中)

      📌 第三方产品分析报告

      ✅ COA系统入驻 | 共享模式

      合成参考文献


      参考文献:10.1111/j.1476-5381.1994.tb14022.x
      摘要:la Rochelle CD, Grosset A, O'Connor SE. Comparison of the haemodynamic profiles of elgodipine and nicardipine in the anaesthetized dog. British J Pharmacology. 1994 Jan;111(1):49–56. doi: 10.1111/j.1476-5381.1994.tb14022.x.
      参考文献:10.1007/bf00054190
      摘要:van Woerkens LJ, Baas NR, van der Giessen WJ, Verdouw PD. Cardiovascular effects of the novel potassium channel opener bimakalim in conscious pigs after myocardial infarction: a comparative study with nicorandil. Cardiovasc Drugs Ther. 1992 Aug;6(4):409–17. doi: 10.1007/bf00054190.
      📝 需求与反馈
      尽可能描述清楚需求与问题信息
      ×

      通知